Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Histamine release induced from mast cells by active components of compound 48/80.
Koibuchi Y, Ichikawa A, Nakagawa M, Tomita K. Koibuchi Y, et al. Eur J Pharmacol. 1985 Sep 24;115(2-3):163-70. doi: 10.1016/0014-2999(85)90687-9. Eur J Pharmacol. 1985. PMID: 2415369
Effect of the tridecamer of compound 48/80, a Ca2+-dependent histamine releaser, on phospholipid metabolism during the early stage of histamine release from rat mast cells.
Dainaka J, Ichikawa A, Koibuchi Y, Nakagawa M, Tomita K. Dainaka J, et al. Among authors: koibuchi y. Biochem Pharmacol. 1986 Nov 1;35(21):3739-44. doi: 10.1016/0006-2952(86)90659-3. Biochem Pharmacol. 1986. PMID: 3778503
Ca-dependent and Ca-independent histamine release from mast cells induced by active components of compound 48/80.
Ichikawa A, Koibuchi Y, Nakagawa M, Tomita K. Ichikawa A, et al. Among authors: koibuchi y. Int J Tissue React. 1987;9(4):325-33. Int J Tissue React. 1987. PMID: 2442114
Binding of active components of compound 48/80 to rat peritoneal mast cells.
Koibuchi Y, Ichikawa A, Nakagawa M, Tomita K. Koibuchi Y, et al. Eur J Pharmacol. 1985 Sep 24;115(2-3):171-7. doi: 10.1016/0014-2999(85)90688-0. Eur J Pharmacol. 1985. PMID: 2415370
Vasorelaxant mechanism of the new vasodilator, FK409.
Isono T, Koibuchi Y, Sato N, Furuichi A, Nishii M, Yamamoto T, Mori J, Kohsaka M, Ohtsuka M. Isono T, et al. Among authors: koibuchi y. Eur J Pharmacol. 1993 Aug 15;246(3):205-12. doi: 10.1016/0922-4106(93)90032-5. Eur J Pharmacol. 1993. PMID: 7901040
Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
Isono T, Sato N, Yamamoto T, Sawada T, Yamazaki S, Miura S, Furuichi A, Ozaki R, Koibuchi Y, Ohtsuka M. Isono T, et al. Among authors: koibuchi y. Eur J Pharmacol. 1994 Aug 1;260(2-3):163-8. doi: 10.1016/0014-2999(94)90333-6. Eur J Pharmacol. 1994. PMID: 7988640
Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries.
Shibata S, Satake N, Sato N, Matsuo M, Koibuchi Y, Hester RK. Shibata S, et al. Among authors: koibuchi y. J Cardiovasc Pharmacol. 1991 Mar;17(3):508-18. doi: 10.1097/00005344-199103000-00022. J Cardiovasc Pharmacol. 1991. PMID: 1711615
Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T, et al. Ohtsuka M, et al. Among authors: koibuchi y. Arzneimittelforschung. 1988 Nov;38(11):1605-18. Arzneimittelforschung. 1988. PMID: 3214444
Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
Matsuo M, Koibuchi Y, Tomoi M, Ono T, Shibayama F, Ohtsuka M. Matsuo M, et al. Among authors: koibuchi y. Arzneimittelforschung. 1989 May;39(5):576-9. Arzneimittelforschung. 1989. PMID: 2757673
Effects of nilvadipine, a new calcium entry blocker, on systemic blood pressure, cardiac hypertrophy and venous distensibility in spontaneously hypertensive rats.
Ohtsuka M, Sakai S, Miura S, Kurosaki M, Koibuchi Y, Ono T, Shibayama F. Ohtsuka M, et al. Among authors: koibuchi y. Arch Int Pharmacodyn Ther. 1989 Sep-Oct;301:228-45. Arch Int Pharmacodyn Ther. 1989. PMID: 2533860
104 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback